Alfred Sandrock, President and CEO at Voyager Therapeutics, Inc. (VYGR), sold 10,885 shares at $3.43 ($37K) on 2025-04-02, disclosed to the SEC on 2025-04-04.
Open-market sale of $37k VYGR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $50K | — | Filing → |